Concepedia

Anjali Babbar

AB

Statistics

Publications

3

Citations

2.1K

H-Index

3

Active since

2016

Affiliations

Wellspring Biosciences (United States)(Current)

Kura Oncology (United States)

Anjali Babbar is an author at Wellspring Biosciences (United States) specializing in ligand binding, enzyme inhibition, and kras g12c inhibition.

Publications per year

2016–2018

3

Publications

3

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li et al. · Cell · 2018 · 1.2K citations · Full text

, , +12

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

Matthew P. Patricelli, Matthew R. Janes, Lian‐Sheng Li et al. · Cancer Discovery · 2016 · 754 citations · Full text

, , +17

The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors

Rasmus Hansen, Ulf Peters, Anjali Babbar et al. · Nature Structural & Molecular Biology · 2018 · 149 citations

, , +14

1–3 of 3